规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Acetyl-CoA carboxylase-alpha (ACCA) is a rate-limiting enzyme in long chain fatty acid synthesis, playing a critical role in cellular energy storage and lipid synthesis. TOFA (5-tetradecyloxy-2-furoic acid), an allosteric inhibitor of ACCA, is cytotoxic to lung cancer cells NCI-H460 and colon carcinoma cells HCT-8 and HCT-15, with IC50s at approximately 5.0, 5.0, and 4.5 μg/ml, respectively. TOFA at 1.0-20.0 μg/ml effectively blocked fatty acid synthesis and induced cell death in a dose-dependent manner[2]. TOFA was also cytotoxic to COC1 and COC1/DDP cells with IC50s of ~26.1 and 11.6 µg/ml, respectively. It inhibited the proliferation of the cancer cells examined in a time and dose dependent manner, arrested the cells in the G0/G1 cell cycle phase and induced apoptosis. In a human ovarian cancer mouse xenograft model, tumor growth rate was significantly inhibited by TOFA compared with the DMSO-treated control mice (1649 ± 356.3 vs. 5128 ± 390.4 mm3)[3]. |
Concentration | Treated Time | Description | References | |
Daudi cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
P493-6 cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
4188 cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
CD8+ T cells | 1 µM | 5 days | Inhibited CD8+ T cell proliferation | J Transl Med. 2023 Jul 4;21(1):434. |
CD8+ T cells | 1 µM | Decreased IFN-γ, granzyme B, perforin levels | J Transl Med. 2023 Jul 4;21(1):434. | |
CD8+ T cells | 1 µM | 24 hours | Reduced CD69 membrane expression | J Transl Med. 2023 Jul 4;21(1):434. |
K562 cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
Ramos cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
BSC40 cells | 154 µM | 16 hours | To evaluate the impact of TOFA on vaccinia virus yield. Results showed TOFA significantly inhibited viral yield by 95-fold, with partial rescue (8-fold) provided by exogenous palmitate. | PLoS Pathog. 2014 Mar 20;10(3):e1004021. |
PBMCs | 0.08–2 µM | 2 days | TOFA reversed Th17/Treg imbalance and inhibited IL-2–induced STAT1/3 phosphorylation. | JCI Insight. 2022 Dec 8;7(23):e162335. |
HEK-293T cells | 5 µM | 23 hours | Combination of TOFA with pimozide significantly enhanced antiviral effects. | Nat Commun. 2016 May 12;7:11320. |
PBMCs | 0.08–10 µM | 24 hours | TOFA cytotoxicity was assessed using a CCK8 assay, and we found no substantial cytotoxicity of the drug when concentrations less than 10 μM were used. | JCI Insight. 2022 Dec 8;7(23):e162335. |
CCRF-CEM cells | 0.3, 1, 3, 10 μg/mL | 24-48 hours | Inhibition of lipogenesis leads to apoptosis | Cancer Metab. 2021 Aug 16;9(1):31. |
Human bone marrow-derived stromal cells (hBMSCs) | 200, 400, or 800 nM | 3 days | Under non-inflammatory conditions, Tofa treatment significantly decreased the gene expression of Runx2 and Dlx5 (p <0.05) and increased the gene expression of PPAR g2, C/EBPa, and Perilipin 1 (p <0.05). Under inflammatory conditions, Tofa limited the negative effect of TNF a on BMAd differentiation (p <0.05). | Front Endocrinol (Lausanne). 2022 Jul 6;13:881699. |
Human naive CD4 T cells | 10 µM | 4 days | TOFA significantly increased IL-9 production by inhibiting ACC1 and reduced the proportion of Foxp3+ cells. Exogenous oleic acid restored IL-9 levels in TOFA-treated cells. | Front Immunol. 2024 Dec 23;15:1509408. |
Normal human epidermal keratinocytes (NHEKs) | 1 µM | 48 hours | Inhibited production and secretion of CXCL9 and CXCL10 | J Transl Med. 2023 Jul 4;21(1):434. |
U2OS cells | 10 µM | 48 hours | TOFA inhibited lipid accumulation, promoted early slippage, reduced cellular stress and enhanced survival of antimitotic-treated cells | Cell Death Discov. 2018 Nov 27;4:109. |
Rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) | 2.5 µM | 48 hours | Investigate the effects of TOFA on gene expression in RA-FLS, showing that TOFA primarily downregulated gene expression, affecting interferon signaling pathways. | Arthritis Res Ther. 2024 Oct 11;26(1):178. |
U87 cells | 39.98 µM (IC50) | 5 days | TOFA showed an IC50 value of 39.98 µM for U87 cells, indicating inhibitory effects on TMZ-sensitive cells. | Acta Pharmacol Sin. 2023 Mar;44(3):670-679. |
U87R cells | 7.51 µM (IC50) | 5 days | TOFA showed an IC50 value of 7.51 µM for U87R cells, indicating inhibitory effects on TMZ-resistant cells. | Acta Pharmacol Sin. 2023 Mar;44(3):670-679. |
HeLa cells | 25 µM | 7 hours | TOFA significantly reduced viral RNA synthesis and release, with no significant effect on cell viability. | Nat Commun. 2016 May 12;7:11320. |
Administration | Dosage | Frequency | Description | References | ||
Sprague-Dawley rats | Cecal ligation and perforation (CLP)-induced sepsis model | Intragastric administration | 1 mg/kg, 3 mg/kg, 10 mg/kg | Every 6 hours for 7 days | To evaluate the effect of TOFA on the survival rate of septic rats and its role in acute lung injury. The results showed that TOFA (10 mg/kg) significantly improved the survival rate of septic rats and reduced lung histopathological damage and inflammatory factor expression | J Inflamm (Lond). 2023 Feb 3;20(1):5 |
New Zealand white rabbits | Experimental rheumatoid arthritis (e-RA) | Oral | 10 mg/kg | Once daily for two weeks | To evaluate the effect of JAK inhibitors on muscle remodeling in an experimental RA model. TOFA significantly improved muscle mass and structural parameters, reduced the expression of muscle atrophy-related genes, and increased creatine kinase (CK) levels in muscle. | Int J Mol Sci. 2023 Aug 24;24(17):13181 |
New Zealand white rabbits | Antigen-induced arthritis model | Oral gavage | 10 mg/kg | Once daily for 2 weeks | To investigate the early effects of TOFA on intra-joint JAK/STAT-dependent signaling during flare-up reactions in arthritis. Results showed that TOFA partially improved synovitis, reduced levels of pSTAT1 and SOCS1, but had no effect on pSTAT3 or SOCS3. | J Inflamm (Lond). 2019 Jan 29;16:2 |
C57BL/6 mice | Adult Mice footpad injection model | Intraperitoneal injection | 25 mg/kg | Pretreated for at least 3 days before infection and assessed 18 h p.i. | TOFA significantly reduced CHIKV replication. | Nat Commun. 2016 May 12;7:11320. |
C57BL6/J mice | GPx1/2-DKO Mice model | Oral | 30 mg/kg | Once daily for 6 or 13 days | To evaluate the efficacy of TOFA on very-early-onset ileocolitis in GPx1/2-DKO mice. Results showed that TOFA significantly inhibited crypt apoptosis and increased crypt density, but did not affect Mice growth. | Life Sci. 2019 Dec 15;239:116884 |
C57BL/6 mice | Vitiligo Mice model | Intraperitoneal injection | 5 mg/kg | Once every other day for five weeks | Alleviated the extent of depigmentation and reduced CD8+ T cell skin infiltration | J Transl Med. 2023 Jul 4;21(1):434. |
Mice | NSG mice | Intraperitoneal injection | 5.5 μg/ml | 4 days | Inhibition of lipogenesis delays tumor progression | Cancer Metab. 2021 Aug 16;9(1):31. |
Lewis rats | Fisher-to-Lewis rat model of kidney transplantation | Oral (mixed with food) | 50 mg/kg and 100 mg/kg | From the third week post-transplantation until the end of the study (12 weeks) | TOFA prolonged graft survival, preserved tubular and glomerular structures and reduced humoral damage characterized by C4d deposition. TOFA was able to reduce donor-specific antibodies. In addition, T and natural killer (NK) cell graft infiltration was reduced in TOFA-treated rats. | Transplantation. 2018 Jul;102(7):1075-1084 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.08mL 0.62mL 0.31mL |
15.41mL 3.08mL 1.54mL |
30.82mL 6.16mL 3.08mL |
CAS号 | 54857-86-2 |
分子式 | C19H32O4 |
分子量 | 324.46 |
SMILES Code | O=C(C1=CC=C(OCCCCCCCCCCCCCC)O1)O |
MDL No. | MFCD01726059 |
别名 | |
运输 | 蓝冰 |
InChI Key | CZRCFAOMWRAFIC-UHFFFAOYSA-N |
Pubchem ID | 115175 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 10 mg/mL(30.82 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|